Hemophilia Treatment Market Size and Growth 2030

Hemophilia Treatment Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, and Antifibrinolytic Agents), Disease (Hemophilia A, Hemophilia B, and Hemophilia C), Treatment Type (On-demand and Prophylaxis), Therapy (Replacement Therapy, ITI Therapy, Gene Therapy, and Antibody Therapy), End User (Hospitals & Clinics, Hemophilia Treatment Centers, and Ambulatory Surgical Centres), and Geography

  • Report Code : TIPRE00008241
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

The hemophilia treatment market size in 2021 stood at US$ 14.44 billion and is projected to reach US$ 23.53 billion by 2031 from US$ XX billion in 2023. The market is expected to register a CAGR of 5.1% in 2023–2031. AAV (adeno-associated virus) based gene therapy is a new treatment for hemophilia is likely to remain a key hemophilia treatment market trend.

Hemophilia Treatment Market Analysis

The market is being driven primarily by the presence of numerous players and various products in pipeline phases. The increase in R&D studies for haemophilia treatments, the increase in target population, and the prevalence of haemophilia contribute to the growth of the hemophilia treatment market. Furthermore, rising awareness of haemophilia disorders and increasing government funding for early identification in neonates are expected to drive market growth.

Hemophilia Treatment Market Overview

Hamophilia is a genetic bleeding disorder in which blood clotting factors are defective or lacking, causing internal and external bleeding. Significant technological advances in haemophilia treatment products have resulted in the availability of enhanced treatment alternatives for haemophilia management in the population. The demand for new haemophilia treatment options is increasing as the target population grows and the number of diagnostic procedures increases worldwide.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Hemophilia Treatment Market: Strategic Insights

Hemophilia Treatment Market

  • CAGR (2023 - 2031)
    5.1%
  • Market Size 2021
    US$ 14.44 Billion
  • Market Size 2031
    US$ 23.53 Billion

Market Dynamics

GROWTH DRIVERS
  • Rise in Favorable Government Initiatives Increasing Prevalence of Hemophilia
FUTURE TRENDS
  • Research Activities and Product Innovations
OPPORTUNITIES
  • New Treatment for Hemophilia

Key Players

  • Bayer AG,
  • Sanofi,
  • F. Hoffmann-la Roche Ltd.,
  • Kedrion S.P.A.,
  • CSL Limited,
  • Biotest AG,
  • Pfizer Inc.,
  • Novo Nordisk A/S,
  • Octapharma AG,
  • Baxter International Inc.,

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Product
  • Plasma Derived Coagulation Factor Concentrates
  • Recombinant Coagulation Factor Concentrates
  • Desmopressin
  • Antifibrinolytic Agents
Disease
  • Hemophilia A
  • Hemophilia B
  • Hemophilia C
Treatment Type
  • On-demand
  • Prophylaxis
Therapy
  • Replacement Therapy
  • ITI Therapy
  • Gene Therapy
  • Antibody Therapy
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Hemophilia Treatment Market Drivers and Opportunities

Rise in Favorable Government Initiatives to Favor Market Growth

An increase in several government initiatives is expected to boost healthcare industry growth over the forecast period. Organizations such as the World Hemophilia Organization and governments of several countries carry out awareness and diagnosis programs. For instance, Health Resources and Services Administration (HRSA) Maternal and Child Health Bureau (MCHB), with funding from HRSA, hemophilia treatment center (HTCs) deliver critical, complete multi-disciplinary facilities, such as physical therapy charges, social work, and case management services that are not characteristically enclosed by insurance. Government efforts to improve public health and treat deprived people will boost the growth of the hemophilia treatment market.

Research Activities and Product Innovations

Over the last five years, many hemophilia treatment products that are currently used in several disciplines have been developed. For instance, in February 2020, Novo Nordisk introduced an antihemophilic product, Esperoct, to reduce hemophilia effect in adults and children with hemophilia A.

Hemophilia Treatment Market Report Segmentation Analysis

Key segments that contributed to the derivation of the hemophilia treatment market analysis are product, disease, treatment type, therapy, and end user.

  • Based on product, the hemophilia treatment market is divided into plasma derived coagulation factor concentrates, recombinant coagulation factor concentrates, desmopressin, and antifibrinolytic agents. The market is further divided on the basis of plasma derived coagulation factor concentrates into factor VIII, factor IX, factor XII, activated prothrombin complex concentrate, and von willebrand factor. The recombinant coagulation factor concentrates segment is further segmented into factor VIII and factor IX. The plasma derived coagulation factor concentrates segment held a larger market share in 2023.
  • By disease, the market is segmented into hemophilia A, hemophilia B, and hemophilia C. The hemophilia A segment held the largest share of the market in 2023.
  • In terms of treatment type, the market is bifurcated into on-demand and prophylaxis. The prophylaxis segment dominated the market in 2023.
  • In terms of therapy, the market is bifurcated into replacement therapy, ITI therapy, gene therapy, and antibody therapy. The prophylaxis segment dominated the market in 2023.
  • By end user, the market is segmented into hospitals & clinics, hemophilia treatment centers, and ambulatory surgical centres. The hospitals and clinics segment held the largest share of the market in 2023.

Hemophilia Treatment Market Share Analysis by Geography

The geographic scope of the hemophilia treatment market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the hemophilia treatment market. Factors such as the increasing number of surgical procedures, improvement in the healthcare infrastructure, and the availability of technological advancements in the region are leading to the growth of the hemophilia treatment market in North America.  

Hemophilia Treatment Market Report Scope

Report Attribute Details
Market size in 2021 US$ 14.44 Billion
Market Size by 2031 US$ 23.53 Billion
Global CAGR (2023 - 2031) 5.1%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Product
  • Plasma Derived Coagulation Factor Concentrates
  • Recombinant Coagulation Factor Concentrates
  • Desmopressin
  • Antifibrinolytic Agents
By Disease
  • Hemophilia A
  • Hemophilia B
  • Hemophilia C
By Treatment Type
  • On-demand
  • Prophylaxis
By Therapy
  • Replacement Therapy
  • ITI Therapy
  • Gene Therapy
  • Antibody Therapy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Bayer AG,
  • Sanofi,
  • F. Hoffmann-la Roche Ltd.,
  • Kedrion S.P.A.,
  • CSL Limited,
  • Biotest AG,
  • Pfizer Inc.,
  • Novo Nordisk A/S,
  • Octapharma AG,
  • Baxter International Inc.,
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    Hemophilia Treatment Market News and Recent Developments

    The hemophilia treatment market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for hemophilia treatment:

    • The Japanese Ministry of Health, Labor, and Welfare (MHLW) has granted marketing authorization for ALTUVIIIO [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein], a first-in-class, high-sustained factor VIII replacement therapy. ALTUVIIIO is indicated for control of bleeding tendency in patients with hemophilia A (factor VIII deficiency). ALTUVIIIO was also recently approved by the Taiwan Food and Drug Administration for treatment of adults and children with hemophilia A on August 31, 2023. (Source: Sanofi, Press Release, 2023)
    • Takeda Pharmaceutical Company Limited (“Takeda”) announced the U.S. availability of myPKFiT for ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated], a web-based software and mobile application that is the first and only pharmacokinetic (PK)-dosing software approved by the U.S. Food and Drug Administration (FDA) for hemophilia A patients 12 and older and weighing at least 29 kg treated with ADYNOVATE. (Source: Takeda Pharmaceutical Company Limited, Press Release, 2020)

    Hemophilia Treatment Market Report Coverage and Deliverables

    The “Hemophilia Treatment Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    Product ; Disease ; Treatment Type ; Therapy ; End User , and Geography

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • 3.1 Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • 3.2 Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • 3.3 Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • 3.4 Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Hemophilia Treatment Market